How sudapyridine interacts with other drugs and food in healthy adults
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests how a new drug, sudapyridine, interacts with two common medicines (itraconazole and rifampin) and whether food changes how the drug is absorbed. It is for healthy adults to help find the right dosing and safety for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult of Chinese background, aged 18 to 50.
- Your body mass index (BMI) is between 18 and 28.
- You have no significant ongoing health conditions or recent surgeries that could affect the study.
- You are not taking certain medications or supplements that could interfere with the study drug.
- You are willing to avoid grapefruit, pomelo, and similar foods during the trial.
- You agree to use effective contraception for up to 6 months after the study (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how Sudapyridine (WX-081) moves through the body in healthy Chinese men. It helps researchers understand the drug's effects and safety before moving to later studies.
This Phase 3 trial tests an oral medicine (Sudapyridine/WX-081) to treat people with rifampicin-resistant pulmonary tuberculosis. It compares how well the study drug works when you stop prior tuberculosis medicines and go through a short “washout” period first.
This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.
This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.
This study checks how other medicines or foods affect the RSS0343 tablet in healthy adults. Participating helps researchers make the drug safer and more effective for future patients.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
Hear when a new Rifampicin-Resistant Pulmonary Tuberculosis Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.